Abstract
Potential drug targets for the disease treatment can be identified from microarray studies on differential gene expression of patients and healthy participants. Here, we describe a method to use the information of differentially expressed (DE) genes obtained from microarray studies to build molecular interaction networks for identification of pivotal molecules as potential drug targets. The quality control and normalization of the microarray data are conducted with R packages simpleaffy and affy, respectively. The DE genes with adjusted P values less than 0.05 and log fold changes larger than 1 or less than −1 are identified by limma package to construct a molecular interaction network with InnateDB. The genes with significant connectivity are identified by the Cytoscape app jActiveModules. The interactions among the genes within a module are tested by psych package to determine their associations. The gene pairs with significant association and known protein structures according to the Protein Data Bank are selected as potential drug targets. As an example for drug target screening, we demonstrate how to identify potential drug targets from a molecular interaction network constructed with the DE genes of significant connectivity, using a microarray dataset of type 2 diabetes mellitus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schena M, Shalon D, Davis R, Brown P (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467–470
Bumgarner R (2013) DNA microarrays: types, applications and their future. Curr Protoc Mol Biol 6137:1–17
Affymetrix (2007) Data sheet: genechip human genome U133 arrays. Proc Natl Acad Sci U S A 2007:1–8
Lander ES, Linton LM, Birren B et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860–921. https://doi.org/10.1038/35057062
Venter JC, Adams MD, Myers EW et al (2001) The sequence of the human genome. Science 291:1304–1351. https://doi.org/10.1126/science.1058040
Wang Y, Miao ZH, Pommier Y et al (2007) Characterization of mismatch and high-signal intensity probes associated with Affymetrix genechips. Bioinformatics 23:2088–2095. https://doi.org/10.1093/bioinformatics/btm306
Palacios G, Quan P, Jabado OJ et al (2007) Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis 13:73–81. https://doi.org/10.3201/eid1301.060837
Cowell JK, Hawthorn L (2007) The application of microarray technology to the analysis of the cancer genome. Curr Mol Med 7:103–120. https://doi.org/10.2174/156652407779940387
Smyth G (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:1–26. https://doi.org/10.2202/1544-6115.1027
Watts DJ, Strogatz SH (1998) Collective dynamics of’small-world’ networks. Nature 393:440–442. https://doi.org/10.1038/30918
Hartwell LH, Hopfield JJ, Leibler S et al (1999) From molecular to modular cell biology. Nature 402:C47–C52. https://doi.org/10.1038/35011540
Barabási A-L, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12:56–68. https://doi.org/10.1038/nrg2918.Network
IDF diabetes atlas–Home. http://www.diabetesatlas.org/
Beckman JA, Paneni F, Cosentino F et al (2013) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J 34:2444–2456. https://doi.org/10.1093/eurheartj/eht142
Creager MA, Lüscher TF, Cosentino F et al (2003) Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: part I. Circulation 108:1527–1532. https://doi.org/10.1161/01.CIR.0000091257.27563.32
Jung CH, Baek AR, Kim KJ et al (2013) Association between cardiac autonomic neuropathy, diabetic retinopathy and carotid atherosclerosis in patients with type 2 diabetes. Endocrinol Metab (Seoul) 28:309–319. https://doi.org/10.3803/EnM.2013.28.4.309
Lin Y, Sun Z (2010) Current views on type 2 diabetes. J Endocrinol 204:1–11. https://doi.org/10.1677/JOE-09-0260
Fu Z, Gilbert ER, Liu D (2013) Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev 9:25–53. https://doi.org/10.2174/157339913804143225
Majithia AR, Florez JC (2009) Clinical translation of genetic predictors for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 16:100–106. https://doi.org/10.1097/MED.0b013e3283292354
Prokopenko I, McCarthy MI, Lindgren CM (2008) Type 2 diabetes: new genes, new understanding. Trends Genet 24:613–621. https://doi.org/10.1016/j.tig.2008.09.004
Ridderstråle M, Groop L (2009) Genetic dissection of type 2 diabetes. Mol Cell Endocrinol 297:10–17. https://doi.org/10.1016/j.mce.2008.10.002
Stančáková A, Laakso M (2016) Genetics of type 2 diabetes. Endocr Dev 31:203–220. https://doi.org/10.1159/000439418
Dominguez V, Raimondi C, Somanath S et al (2011) Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic?? Cells. J Biol Chem 286:4216–4225. https://doi.org/10.1074/jbc.M110.200295
Brazma A, Hingamp P, Quackenbush J et al (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29:365–371. https://doi.org/10.1038/ng1201-365
Yeung N, Cline MS, Kuchinsky A et al (2008) Exploring biological networks with Cytoscape software. Curr Protoc Bioinformatics. https://doi.org/10.1002/0471250953.bi0813s23
Gautier L, Cope L, Bolstad BM et al (2004) Affy – analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20:307–315. https://doi.org/10.1093/bioinformatics/btg405
Neuwirth E. (2014) RColorBrewer: ColorBrewer palettes. R Packag version 11–2: https://cran.R--project.org/package=RColorBrewer. https://cran.r-project.org/web/packages/RColorBrewer/index.html
Wilson CL, Miller CJ (2005) Simpleaffy: a bioconductor package for Affymetrix quality control and data analysis. Bioinformatics 21:3683–3685. https://doi.org/10.1093/bioinformatics/bti605
Ritchie ME, Phipson B, Wu D et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47. https://doi.org/10.1093/nar/gkv007
Carlson M (2016) hgu133a.db: Affymetrix Human Genome U133 Set annotation data (chip hgu133a)
Revelle W (2017) Psych: procedures for personality and psychological research. Northwestern University, Evanston, Illinois, USA. https://CRAN.R-project.org/package=psych Version = 1.7.5
Gautier L, Irizarry R, Cope L (2009) Description of affy. Changes 2009:1–29
Breuer K, Foroushani AK, Laird MR (2013) InnateDB: systems biology of innate immunity and beyond–recent updates and continuing curation. Nucleic Acids Res 41:1228–1233. https://doi.org/10.1093/nar/gks1147
Lynn DJ, Winsor GL, Chan C (2008) InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol Syst Biol 4:218. https://doi.org/10.1038/msb.2008.55
Orchard S, Salwinski L, Kerrien S (2007) The minimum information required for reporting a molecular interaction experiment (MIMIx). Nat Biotechnol 25:894–898. https://doi.org/10.1038/nbt1324
Cline MS, Smoot M, Cerami E (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2:2366–2382. https://doi.org/10.1038/nprot.2007.324
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Yuen, S.C., Zhu, H., Leung, Sw. (2018). Building Molecular Interaction Networks from Microarray Data for Drug Target Screening. In: Gore, M., Jagtap, U. (eds) Computational Drug Discovery and Design. Methods in Molecular Biology, vol 1762. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7756-7_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7756-7_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7755-0
Online ISBN: 978-1-4939-7756-7
eBook Packages: Springer Protocols